BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 29668937)

  • 1. Knockdown of Smad7 With a Specific Antisense Oligonucleotide Attenuates Colitis and Colitis-Driven Colonic Fibrosis in Mice.
    Izzo R; Bevivino G; De Simone V; Sedda S; Monteleone I; Marafini I; Di Giovangiulio M; Rizzo A; Franzè E; Colantoni A; Ortenzi A; Monteleone G
    Inflamm Bowel Dis; 2018 May; 24(6):1213-1224. PubMed ID: 29668937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of Smad7 with a specific antisense oligonucleotide facilitates TGF-beta1-mediated suppression of colitis.
    Boirivant M; Pallone F; Di Giacinto C; Fina D; Monteleone I; Marinaro M; Caruso R; Colantoni A; Palmieri G; Sanchez M; Strober W; MacDonald TT; Monteleone G
    Gastroenterology; 2006 Dec; 131(6):1786-98. PubMed ID: 17087939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of colonic fibrosis by Boswellia and Scutellaria extracts in rats with colitis induced by 2,4,5-trinitrobenzene sulphonic acid.
    Latella G; Sferra R; Vetuschi A; Zanninelli G; D'Angelo A; Catitti V; Caprilli R; Gaudio E
    Eur J Clin Invest; 2008 Jun; 38(6):410-20. PubMed ID: 18489401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue inhibitor of metalloproteinase-3 regulates inflammation in human and mouse intestine.
    Monteleone I; Federici M; Sarra M; Franzè E; Casagrande V; Zorzi F; Cavalera M; Rizzo A; Lauro R; Pallone F; MacDonald TT; Monteleone G
    Gastroenterology; 2012 Nov; 143(5):1277-1287.e4. PubMed ID: 22819866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Smad7 Knockdown Restores Aryl Hydrocarbon Receptor-mediated Protective Signals in the Gut.
    Monteleone I; Marafini I; Zorzi F; Di Fusco D; Dinallo V; Rizzo A; Sileri P; Sica G; Monteleone G
    J Crohns Colitis; 2016 Jun; 10(6):670-7. PubMed ID: 26818761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CCL20 Is Negatively Regulated by TGF-β1 in Intestinal Epithelial Cells and Reduced in Crohn's Disease Patients With a Successful Response to Mongersen, a Smad7 Antisense Oligonucleotide.
    Marafini I; Monteleone I; Dinallo V; Di Fusco D; De Simone V; Laudisi F; Fantini MC; Di Sabatino A; Pallone F; Monteleone G
    J Crohns Colitis; 2017 May; 11(5):603-609. PubMed ID: 28453765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Smad7 in inflammatory bowel diseases.
    Monteleone G; Caruso R; Pallone F
    World J Gastroenterol; 2012 Oct; 18(40):5664-8. PubMed ID: 23155305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Smad7 antisense oligonucleotide-based therapy for inflammatory bowel diseases.
    Zorzi F; Angelucci E; Sedda S; Pallone F; Monteleone G
    Dig Liver Dis; 2013 Jul; 45(7):552-5. PubMed ID: 23287011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A murine model of chronic inflammation-induced intestinal fibrosis down-regulated by antisense NF-kappa B.
    Lawrance IC; Wu F; Leite AZ; Willis J; West GA; Fiocchi C; Chakravarti S
    Gastroenterology; 2003 Dec; 125(6):1750-61. PubMed ID: 14724828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Smad3 loss confers resistance to the development of trinitrobenzene sulfonic acid-induced colorectal fibrosis.
    Latella G; Vetuschi A; Sferra R; Zanninelli G; D'Angelo A; Catitti V; Caprilli R; Flanders KC; Gaudio E
    Eur J Clin Invest; 2009 Feb; 39(2):145-56. PubMed ID: 19200168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Smad7 and its Potential as Therapeutic Target in Inflammatory Bowel Diseases.
    Laudisi F; Dinallo V; Di Fusco D; Monteleone G
    Curr Drug Metab; 2016; 17(3):303-6. PubMed ID: 26651974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TGF-Beta signaling manipulation as potential therapy for IBD.
    Marafini I; Zorzi F; Codazza S; Pallone F; Monteleone G
    Curr Drug Targets; 2013 Nov; 14(12):1400-4. PubMed ID: 23489130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-13 signaling via IL-13R alpha2 induces major downstream fibrogenic factors mediating fibrosis in chronic TNBS colitis.
    Fichtner-Feigl S; Young CA; Kitani A; Geissler EK; Schlitt HJ; Strober W
    Gastroenterology; 2008 Dec; 135(6):2003-13, 2013.e1-7. PubMed ID: 18938165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of Smad7 in Inflammatory Diseases of the Gut and Colon Cancer.
    Troncone E; Marafini I; Stolfi C; Monteleone G
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33920230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The TGF-β/Smad System in IBD Pathogenesis.
    Sedda S; Marafini I; Dinallo V; Di Fusco D; Monteleone G
    Inflamm Bowel Dis; 2015 Dec; 21(12):2921-5. PubMed ID: 26230862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blocking Smad7 restores TGF-beta1 signaling in chronic inflammatory bowel disease.
    Monteleone G; Kumberova A; Croft NM; McKenzie C; Steer HW; MacDonald TT
    J Clin Invest; 2001 Aug; 108(4):601-9. PubMed ID: 11518734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting TGF-beta1 by employing a vaccine ameliorates fibrosis in a mouse model of chronic colitis.
    Ma Y; Guan Q; Bai A; Weiss CR; Hillman CL; Ma A; Zhou G; Qing G; Peng Z
    Inflamm Bowel Dis; 2010 Jun; 16(6):1040-50. PubMed ID: 19924805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2,4,6-trinitrobenzene sulfonic acid-induced chronic colitis with fibrosis and modulation of TGF-β1 signaling.
    Loeuillard E; Bertrand J; Herranen A; Melchior C; Guérin C; Coëffier M; Aziz M; Déchelotte P; Savoye G; Marion-Letellier R
    World J Gastroenterol; 2014 Dec; 20(48):18207-15. PubMed ID: 25561788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blockade of STAT3 by antisense oligonucleotide in TNBS-induced murine colitis.
    Bai A; Hu P; Chen J; Song X; Chen W; Peng W; Zeng Z; Gao X
    Int J Colorectal Dis; 2007 Jun; 22(6):625-35. PubMed ID: 17089128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alternative Splice Forms of CYLD Mediate Ubiquitination of SMAD7 to Prevent TGFB Signaling and Promote Colitis.
    Tang Y; Reissig S; Glasmacher E; Regen T; Wanke F; Nikolaev A; Gerlach K; Popp V; Karram K; Fantini MC; Schattenberg JM; Galle PR; Neurath MF; Weigmann B; Kurschus FC; Hövelmeyer N; Waisman A
    Gastroenterology; 2019 Feb; 156(3):692-707.e7. PubMed ID: 30315770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.